AlphAIAlphAI — Financial news for AI agents
theglobeandmail.comSEP 212 min read$OURA

Smart ring maker Oura targets $15.62-billion valuation in U.S. IPO

Oura, a smart ring maker, aims for a $15.62 billion valuation in its U.S. IPO, selling 50 million shares at $40-$44 each. Revenue grew 74% YoY to $1.21 billion in nine months. Eli Lilly and Dragoneer expressed interest in purchasing shares. The IPO tests investor appetite for consumer tech amid market volatility.

Original reporting
theglobeandmail.com
Published Sep 21, 2026, 2:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 21, 2026, 3:40 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Smart ring maker Oura targets $15.62-billion valuation in U.S. IPO — source image
Source · theglobeandmail.com
Decision brief

The 30-second read

$OURABullishHigh
01

Why it matters

The IPO could provide capital for product expansion and increase visibility for wearable health devices.

02

Market read

First major consumer‑tech IPO of the season; could influence upcoming listings.

03

What to watch

Potential regulatory scrutiny on health‑data privacy and competition from established wearables.

Relevance 9/10Novelty 9/10Timing: roadshow kickoff today, IPO pending

Background

Oura is a health‑tech company known for its smart ring that tracks sleep, activity, and heart metrics.

Company-level read

Ticker impact

$OURABullishHigh confidence
Context

Oura announced its US IPO targeting a $15.62 billion valuation and a $2.2 billion raise of 50 million shares at $40‑$44.

Expected impact

Expect strong opening demand; potential first‑day pop of 10‑15% if demand holds.

Evidence & confidence

Large raise size, high valuation, and participation from marquee investors (Eli Lilly, Dragoneer) indicate solid market interest.

Market effects

Sector

Sets tone for other consumer‑tech IPOs in a volatile market.

Regional

Adds to US IPO pipeline, may attract foreign investors to Nasdaq.

Global

Signals investor appetite for health‑tech amid broader market jitteriness.

Counterpoint

What could challenge this read

If market volatility persists, the IPO could be undersubscribed, leading to a weak debut.

Key entities

  • Company
    Oura

    Smart ring maker planning US IPO.

  • Investor
    Eli Lilly

    Pharma company expressing interest in buying up to $100 million of shares.

  • Investor
    Dragoneer

    Investment firm expressing interest in buying up to $300 million of shares.

Read at source← All news

Also covered by

4 outlets

Related articles

SEP 22
$COINMedAI 8/10

Coinbase Opens IPO Access — Oura Is First, But There's a Catch

Coinbase launched a new service allowing eligible U.S. retail customers to request allocations in IPOs, starting with Oura's $2.2B IPO. Oura plans to sell 13.5M shares at $40-$44 each, with a fully diluted valuation of about $15.62B. Coinbase's IPO access prioritizes long-term investors, discouraging early selling.

dailycoin.com2 min
SEP 22
$OURAHighAI 9/10

Smart ring maker Oura targets $2.2 billion in US listing

Oura Inc, a smart ring maker, aims to raise $2.2B in a US IPO, offering 50M shares at $40-$44 each. The company could be valued at $14.1B-$15B. Oura reported a $924.3M net loss on $1.21B revenue for the nine months ended June 30. The IPO is expected to price on September 29, with shares trading on Nasdaq under ticker OURA.

gulfnews.com3 min
SEP 22
$COINHigh

Coinbase IPO News: US Retail Access Opens, With Oura Up First

Coinbase launched a feature allowing eligible US retail customers to request IPO shares, starting with Oura. Oura plans to offer 13.5M shares priced between $40 and $44, listing on Nasdaq as OURA. Coinbase's stock (COIN) rose 3.5% to $201.05 on the news, with a market cap of $53.04B. Oura's IPO is expected to price this week.

coingabbar.com2 min
SEP 21
$OURAHighAI 9/10

Oura smart ring IPO roadshow launches, targets $2.2 billion

Oura Health launched its IPO, aiming to raise $2.2B by selling 50M shares at $40-$44 each, targeting a $15.62B valuation. Trading under 'OURA' on Nasdaq, it sold 3.6M rings in the past year with $1.21B revenue. Eli Lilly and Dragoneer may invest $100M and $300M respectively. The company faces a lawsuit over sleep tracking accuracy claims.

yahoo.com2 min